Noveris Health Sciences is trading 6.67% up at CA$0.08, with no clear company-specific catalyst identified.

  • It closed at CA$0.07 on October 5, after gaining 7.14% that session.
  • No October 6 company announcement was identified; the latest company news surfaced was its September 9 annual-meeting results.
  • The broad market is higher, but available evidence does not establish that it is driving the move. Trading volume or activity details were unavailable.